BIOS Builders Interview with Mark Chao, Co-founder & CEO at TenSixteen Bio April 13, 2022 7:48 pm Leave a Comment
Foresite Labs’ new $173M fund to bankroll fewer startups but ‘big ideas’ fueled by data March 9, 2022 1:55 pm Leave a Comment
Foresite Capital Launches $173M Fund to Support Incubated Companies March 3, 2022 9:46 pm Leave a Comment
TenSixteen Bio Plumbs Somatic Mosaicism for Source of Multiple Diseases February 16, 2022 8:54 pm Leave a Comment
TenSixteen targets dynamic genome to find driver mutations, catch cancer earlier January 28, 2022 9:24 pm Leave a Comment
Foresite and GV pour $40M into startup’s move to CHIP into new disease biology January 27, 2022 11:36 pm Leave a Comment
With Forty Seven co-founder at the helm, new biotech spinout launches to target mutations potentially linked to numerous diseases 7:30 pm Leave a Comment
TenSixteen Bio Launches With $40M Series A To Advance A New Approach To Disease Detection And Treatment 7:29 pm Leave a Comment
Foresite Labs Hatches Big-Data-Driven Companies Destined to Shake up Healthcare January 20, 2022 6:09 pm Leave a Comment